Answers are grounded in this paper and cite their sources.
This document provides expert consensus recommendations for the use of ICD therapy in patient populations underrepresented in clinical trials.
W-K, Slotwiner DJ, Stevenson LW, Varosy PD, Lisa Welikovitch.HRS/ACC/ AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not
No takes yet. Share an insight, caveat, or question.
Kusumoto et al. (2014) studied this question. Implantable cardioverter-defibrillator therapy in patients underrepresented in clinical trials is guided by new expert consensus recommendations from the HRS, ACC, and AHA.
Synapse has enriched 10 related papers. Consider them for comparative context: